3 California Healthcare Stocks Tied To Medi Cal Funding Shifts

California is weighing Proposition 40, a one time 5% wealth tax on billionaires, and that debate reaches straight into the healthcare providers and services stocks tied to Medi Cal and state funding. Capital could shift, team owners might move, and healthcare budgets may be reshaped. This article spotlights three California exposed healthcare stocks that appear positioned on the positive side of this political story.

The three California focused healthcare providers and services stocks below are only a first cut, while the full screen surfaced 22 more companies with equally detailed narratives that are not covered here. If you want to identify which California exposed healthcare providers align best with your thesis, head straight into the California-focused Healthcare Providers and Services screener.

RadNet (RDNT)

Overview: RadNet runs outpatient imaging centers and sells AI driven radiology software that support diagnostic services for health systems across California and beyond.

Operations: RadNet generates about US$2.2b from Imaging Centers and US$114 million from Digital Health, almost entirely from United States customers.

Market Cap: US$5.8b

RadNet matters in this California focused screen because its imaging centers and AI tools intersect directly with how Medi Cal dollars get used in everyday care.

"Ongoing investments in AI powered imaging solutions such as DeepHealth, See Mode and iCAD are now tied to specific productivity gains like shorter thyroid and breast ultrasound slots and high acceptance of AI drafted reports."

What really moves the needle for RadNet now is how one quiet cost pressure interacts with those productivity gains and California payer mix.

Those cost pressures are exactly where the full narrative for RadNet connects the dots, showing how RadNet’s AI gains could be masking deeper shifts in volume, payer mix and capital needs.

Pennant Group (PNTG)

Overview: Pennant Group runs home health, hospice, and senior living facilities across multiple states, including California, tying it directly into Medi Cal linked care funding.

Operations: Pennant Group generates about US$872.9 million from Home Health and Hospice Services, US$221.8 million from Senior Living, and US$7 million from other activities, all in the United States.

Market Cap: US$1.5b

For this California focused screen, Pennant Group matters because its home based care and senior communities plug straight into state backed reimbursement streams for frail and elderly patients.

"The ongoing shift by payers and families toward lower cost, home based care settings relative to institutional care aligns with Pennant Group’s focus on home health and hospice agencies. This can support volume growth and help protect segment margins as demand concentrates in these service lines."

What really deserves attention now is how one quiet funding and debt related pressure could reshape where Pennant’s growing care volumes actually fall to the bottom line.

That funding squeeze is exactly where the full narrative for Pennant Group shows how accelerating volumes, reimbursement mix and leverage risks could interact for Pennant Group’s next chapter.

Privia Health Group (PRVA)

Overview: Privia Health Group runs a physician-enablement platform that helps doctors, health plans and health systems deliver value-based care across the United States.

Operations: Privia Health Group generates about US$2.4b from Healthcare Facilities & Services, all from patients and payers in the United States.

Market Cap: US$2.7b

Privia Health Group matters in this California-focused screen because its platform sits directly in the flow of Medi Cal linked reimbursements and physician group economics when state funding moves.

"Rising value-based attributed lives to 1.64 million across more than 130 contracts, including commercial, Medicare and Medicaid arrangements, increases the pool of medical spend under management, which can translate into higher care margin and earnings as these contracts progress."

The real tension for Privia Health Group now is how one unresolved pressure around scaling free cash flow could shape those margin gains.

That free cash flow question is exactly where the full narrative for Privia Health Group shows whether Privia Health Group’s scaling model is quietly accelerating value or masking harder trade offs ahead.

Seeking Alternatives Before The Crowd?

Fresh ideas move first. Breakout themes can gather momentum quickly, and pricing may shift once everyone is focused on the same stories. Scan these under the radar lists and consider them while they are still less widely followed.

• Explore resilient compounding potential by reviewing a curated list of solid balance sheet and fundamentals (24 results) that keeps financial strength and fundamentals front and center for long term-oriented investors.
• Identify tactical income opportunities by checking out a hand-picked set of 5 dividend fortresses that balance higher yields with an emphasis on durability and cash coverage.
• Follow developments in automation by scanning carefully filtered 95 robotics and automation stocks that connect real-world adoption to revenue models, rather than focusing only on headline-grabbing concepts.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com